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 The gradual and selective loss of retinal ganglion cells
by apoptosis underlies the progression of glaucoma and leads
to a loss of vision. A variety of causal factors have been put
forward that may bring about ganglion cell apoptosis. The rela-
tive contribution of these factors to the onset and progression
of glaucoma however remains unknown. Hypoxia/ischemia
are some of the factors implicated in glaucoma and several
other retinal disease conditions such as diabetic retinopathy
and central retinal artery occlusion [1-6]. The preferential loss
of retinal ganglion cells in the glaucomatous retina corresponds
to the pattern of neuronal degeneration through apoptosis af-
ter experimental ischemia [7,8]. Therefore, a better understand-
ing of the molecular pathways triggered after experimental
ischemia will help to identify factors that determine ganglion
cell loss in glaucoma [9]. Of equal interest are intrinsic
neuroprotective factors/pathways that enable retinal cells to
cope with stressful conditions. The discovery of ischemic pre-
conditioning (IPC, also termed tolerance) provides an ideal
experimental opportunity to study these mechanisms. IPC is
induced by a short 5 min period of ischemia which by itself
does not lead to cell loss. When the retina is challenged by a
full 60-min ischemic insult 24 h later, normally leading to the
degeneration of cells in the inner retina, both a robust protec-
tion against the loss of cells and a preservation of a- and b-
waves in the electroretinogram is observed [10,11]. IPC pro-
vides a transient protective effect lasting 24 to 72 h after the
preconditioning stimulus and depends upon de novo protein
synthesis [10,11]. The mechanism of IPC is not completely
understood, but Hif1 transcription factor [12-14], Hsp27
(Hspb1) upregulation [10,14-16], stimulation of adenosine A1
and A2a receptors [13,17,18], protein kinase C activation [18],
leukocyte rolling inhibition [19], inducible nitric oxide syn-
thase (iNOS) [20], and the opening of mitochondrial potas-
sium-dependent ATP (mKATP) channels [21] have been pro-
posed as underlying factors (see for reviews: [10,22]).
Microarray technology allows for a comprehensive
screening of changes in the expression of genes in different
physiological states. Microarray studies on IPC in rat spinal
cord, rat hippocampus and mouse cortex have identified sev-
eral genes that may be involved, including heat-shock pro-
teins and transcription factors [13,23,24]. The aim of the cur-
rent study is to document the molecular pathways that under-
lie IPC-induced neuroprotection in the retina.
METHODS
Animals and anesthetics:  Animal handling and experimental
procedures were reviewed and approved by the ethical com-
mittee for animal care and use of the Royal Netherlands Acad-
emy for Sciences, acting in accordance with the European
Community Council directive of 24 November 1986 (86/609/
EEC) and the ARVO statement for the use of animals in Oph-
©2007 Molecular Vision
Global gene expression profiling of ischemic preconditioning in the
rat retina
W. Kamphuis,1,2 F. Dijk,1 S. van Soest,1 A.A.B. Bergen1
1Department of Ophthalmogenetics, 2 Department of Cellular Quality Control, Netherlands Institute for Neuroscience NIN-KNAW,
Amsterdam, Netherlands
Purpose: To obtain and analyze the gene expression changes after ischemic preconditioning (IPC) in the rat retina.
Methods: Ischemic damage to the inner retina can be prevented by a short, non-deleterious, ischemic insult of 5 min
applied 24 h preceding a full ischemic insult of 60 min; a phenomenon termed tolerance or IPC. The time course of
changes in gene expression after induction of IPC was assessed by 22K oligonucleotide microarrays, followed by real-
time quantitative polymerase chain reaction (qPCR) validation. Functional pathways of interest were identified by Gene
Ontology-term analysis.
Results: Histology confirmed that IPC induction by 5 min of retinal ischemia results in a complete protection against the
neurodegenerative effects of a 60 min ischemic period applied 24 or 48 h later. The microarray analysis revealed differen-
tial expression of 104 known genes at one or more time points between 1 h and 7 days after IPC. The group of altered
genes contained a significant overrepresentation of genes involved in aminoacyl-tRNA synthetase activity (Iars, Lars,
Cars, Yars, Gars, Tars), amino acid transport (Slc3a2, Slc6a6, Slc7a1, Slc38a2), regulation of transcription (including
Egr1, Egr4, Nr4a1, Nr4a3, c-fos), and cell death (including Anxa1, Trib3). qPCR assays on cDNA of individual animals
confirmed the microarray results.
Conclusions: Endogenous neuroprotection, provoked by ischemic preconditioning is associated with changes in tran-
script levels of several functionally-related groups of genes. During the time window of effective protection, transcript
levels of genes encoding for aminoacyl-tRNA synthetases and for amino acid transport are reduced. These changes sug-
gest that a reduction of translational activity may play a significant role in preconditioning-mediated neuroprotection.
Correspondence to: W. Kamphuis, Department of Ophthalmogenetics,
Netherlands Institute for Neuroscience NIN-KNAW, Meibergdreef
47, 1105 BA Amsterdam, The Netherlands; Phone: tel: 31 20 5665500;
FAX: 31 20 5666121; email: w.kamphuis@nin.knaw.nl
1020thalmic and Vision Research. The procedure to induce tran-
sient ischemia followed by reperfusion has been described in
detail previously [25-27]. In short, adult male Wistar rats
(Harlan, the Netherlands) weighing 200-300 g were anesthe-
tized and mounted onto a stereotactic frame (Stoelting, Wood
Dale, IL). A steel 30-gauge infusion needle (BD Biosciences,
Alphen aan den Rijn, The Netherlands) connected to a saline
reservoir was placed in the middle of the anterior chamber of
the left eye. The reservoir was opened and lifted to 1.70 m.
Ischemia was confirmed by the white anemic fundus reflex.
After 60 min of ischemia, the reservoir was lowered and
reperfusion started immediately. For IPC, 5 min of ischemia
was applied and retinas were isolated after 1 h (n=6), 3 h (n=6),
6 h (n=5), 12 h (n=5), 24 h (n=5), 48 h (n=5), and 7 days
(n=6). Animals were killed by an overdose of sodium-pento-
barbital (Ceva Santa Animale, Maassluis, The Netherlands;
0.8 ml; 60 mg/ml) intraperitoneally. Sham-operated animals,
in which a needle was inserted into the anterior chamber with-
out elevating pressure, were included in each control group to
evaluate the possibility that the process of cannulation itself
induces differences between ischemic and control eyes.
Histology:  A separate group of animals was precondi-
tioned by 5 min of ischemia, and following different intervals
(24 h, 48 h, 7 days; n=3 each group) challenged by 60 min
ischemia. After a delay of 7 days, the animals were sacrificed
for histological assessment of inner plexiform layer thickness
and somata counts in the ganglion cell layer [25].
RNA isolation:  The isolation of total RNA from the retina
has been described in detail [28]. In short, the whole of the
retina was isolated, frozen on dry ice and stored at -80 °C.
Frozen retina was thawed in Trizol (Invitrogen, Breda, The
Netherlands) and homogenized immediately. Total RNA was
isolated following the manufacturer’s instructions. Precipitated
RNA was dissolved in 8 µl RNase-free water. The RNA yield
was around 10 µg/retina (ND-1000 Spectrophotometer;
NanoDrop Technologies, Wilmington, DE) and quality checks
showed sharp ribosomal RNA peaks with minimal degrada-
tion (Agilent Technologies 2100 Bioanalyser, Amstelveen, The
Netherlands).
Experimental set-up and probe generation:  Pooled total
RNA samples were prepared corresponding to each of the time
points after IPC and one additional pooled sample was propared
from all contralateral control retinas (n=36). Each retinal
sample contributed one µg of total RNA to the pooled sample.
For first strand cDNA synthesis, 1.5 µg RNA of the pooled
sample was primed with a T7 Oligo(dT) (Ambion,
Nieuwerkerk a/d lJssel, The Netherlands) primer. Following
second strand cDNA synthesis, in vitro transcription gener-
ated amino allyl-UTP labeled aRNA (Amino Allyl
MessageAmp aRNA kit, Ambion, Nieuwerkerk a/d lJssel, The
Netherlands) with an average yield of 40-60 µg. Electrophero-
grams of the amplified aRNA showed a symmetrical length
distribution with a peak around 1.5 kb, a maximum length of
5.5 kb, and no differences in size distribution between the dif-
ferent samples. The aRNA was coupled to Cy3 or Cy5
monoreactive dyes (Amersham, Eindhoven, The Netherlands)
and purified from excess dye over a Chromaspin-30 column
(Clontech, Westburg, Leusden, The Netherlands). Incorpora-
tion efficiency and yield were determined on a spectropho-
tometer (NanoDrop Technologies).
For microarray hybridization, a common reference de-
sign was used. aRNA of the control-group (30 µg) was la-
beled with Cy3. An aliquot of 1 µg served as the identical
common reference present on all arrays and was hybridized
simultaneously with 1 µg Cy5-labeled aRNA from one of the
experimental or control groups.
Microarrays:  Oligonucleotide arrays were obtained from
Agilent (Amstelveen, The Netherlands; 22K catalog rat array,
60-mer oligonucleotides, product number G4130A); the com-
plete design can be found at Agilent or GEO-NCBI. These
arrays are designed for the simultaneous hybridization of two
aRNA samples labeled with Cy5 (treatment-group) and Cy3
(control). After normalization, the dye ratio represents the tran-
script ratio. On Agilent arrays, gene expression levels are
monitored by a single carefully selected probe (termed fea-
ture) aimed to combine high sensitivity with the least variable
ratio. This approach results in a low technical inter-chip vari-
ability [29,30]. In our experience, the technical reproducibil-
ity between arrays is indeed high: the outcome between two
technical replicates with the same or reversed polarity shows
a correlation around R2=0.77. Hybridization was carried out
according to the protocols described by Agilent. For details
see: Two-color microarray-based gene expression analysis at
Agilent. After hybridization, the slides were washed for 5 min
in 6x SSPE+0.005% N-lauroylsarcosine (Sigma-Aldrich,
Zwijndrecht, The Netherlands) at room temperature, washed
for 1 min in 0.06x SSPE+0.005% N-lauroylsarcosine, dipped
in acetonitril (Sigma-Aldrich, Zwijndrecht, The Netherlands),
and dried with a stream of N2.
Data analysis:  The array images were acquired using an
Agilent microarray scanner set at 5 µm resolution. Images were
loaded into Feature Extraction software (v8.5; Agilent) and
combined with the latest array information (design-file) with
default settings for all parameters including normalization. For
details see feature extraction software user manual v8, at
Agilent. This results in the signal strength of the treatment
(Cy5) and control (Cy3) channels, the relationship between
the two channels in terms of log ratio, the associated p-value
and information concerning various quality control fields. The
arrays studied had on average 22 technically flawed features
(outliers; 0.1%). Images and MAGE files were uploaded to
Rosetta Biosoftware Resolver® system, v5.0. Detailed infor-
mation on the Rosetta Resolver system can be found at Rosetta
Biosoftware (Rosetta Biosoftware, Seattle, WA), and in sev-
eral published papers [31,32]. The complete list of all signa-
tures, log10 ratios, log ratio errors, and p-values is also avail-
able as supplemental data (Appendix 1).
Selection considerations:  The Agilent and Rosetta sys-
tems determine differential expression not on simple constant
fold-change thresholds but upon signal/noise ratios. The Fea-
ture Extraction software extends the accuracy of the data by
propagating errors for each signal and background measured.
Calculations using this propagated error and Rosetta’s error
model yield a log ratio error and p-value for the log ratio of
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1021each feature. The error around log ratios is signal intensity-
dependent. The default additive and multiplicative parameters
have been optimized for the Agilent microarrays (e.g.,
microarrays, protocols, scanner, and feature extraction algo-
rithms). To select appropriate cut-off values, the following was
considered: our study design used pooled-samples for the
microarrays and must be considered as a fast screening tool to
select features of interest, followed by gene ontology analysis
and a series of confirmatory quantitative PCR (qPCRs) on the
individual animals. Several published papers have shown a
high correlation between the data from Agilent’s oligo arrays
and qPCR [33,34]. Based upon previously collected qPCR data
on the transcript levels of 80 different genes in untreated and
ischemia-treated rat retinas, the average biological variability
of transcript levels was estimated to be 41±14% (coefficient
of variation %±S.D.) [26,28]. The arrays present the average
fold-change between 5 IPC-treated animals compared to 36
control retinas. Power calculations show that for transcript
levels with variability of 55% (mean±SD), a >1.7 fold change
will be declared as significantly regulated by qPCR assays
(p<0.05; power 0.80). We therefore selected features with >1.7
fold change. Ranking the micro array data on fold-change,
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Figure 1. Sections of rat retina
stained with the fluorescent DNA-
stain 4,6 diamidino 2 phenylindole
(DAPI).  A: Control, retina of a
sham-treated eye. B: I/R, retina 7
days of reperfusion after 60 min of
ischemia. Note the decrease in thick-
ness of INL and IPL, and the re-
duced number of somata in the gan-
glion cell layer. C: IPC-I/R (24 h),
retina preconditioned by 5 min of
ischemia, followed 24 h later by 60
min of ischemia and sacrificed 7
days later. No histological changes
can be found. D: IPC-I/R (7 days),
retina preconditioned by 5 min of
ischemia, followed 7 days later by
60 min of ischemia and sacrificed 7
days later. The effect of precondi-
tioning has diminished, but the loss
of IPL thickness is still partially pre-
vented. ONL represents outer
nuclear layer, OPL represents outer
plexiform layer, INL represents in-
ner nuclear layer, IPL represents in-
ner plexiform layer, GCL represents
ganglion cell layer. All images were
taken at the same magnification.
Scale bar in A represents 25 µm.
1022some >1.7 fold changes were found to be based on low inten-
sity features just above background. The technical log ratio
error, assigned by Feature Extraction software, was therefore
added as a second criterion (p<0.01).
Preliminary experiments identified a significant dye bias
in 19 features and these were removed from analysis. A set of
56 features were flagged as saturated in most of the arrays and
these features were excluded from analysis. Furthermore, a
set of 25 features (Appendix 1) was excluded from this study
because examination by qPCR showed for these genes highly
variable transcript levels caused by a transfer of small amounts
of lens epithelium during retina isolation [35].
Web tools:  Gene annotation of the genes on the array
was improved using web-based annotation tools DAVID-2006
(National Institute of Allergy and Infectious Diseases (NIAID),
NIH) [36] and Source (Stanford University, Stanford, CA).
Of the 20,280 features, 92% could be linked to a UniGene
Cluster ID; representing 14,127 unique UniGenes. Gene On-
tology (GO) analysis used to identify overrepresented or de-
pleted functional groups of genes and was performed with
GOstat [37] and DAVID-2006 [36]. Lists of selected genes-
of-interest were compared with the total set of genes present
on the array. Fisher’s Exact Test was performed to rank GO-
terms in GOstat. The enrichment calculation performed in
DAVID, called EASE score, is a conservative adjustment to
the Fisher exact probability that weighs significance in favor
of themes supported by more genes [36,38,39]. The derived
P-values are a score system to organize the view and to facili-
tate exploration rather than a strict decision making line; scores
p<0.01 were considered to be of potential interest.
Real time quantitative polymerase chain reaction:  For
qPCR, 2 µg total RNA from each individual retina was dis-
solved in 4 µl H2O, DNase I treated (0.5 unit DNAseI, Ampli-
fication Grade, Invitrogen). The RNA sample was reverse tran-
scribed into first strand cDNA with 100 U Superscript III Re-
verse Transcriptase (Invitrogen) and 50 ng random hexamer
primers. The resulting cDNA sample served as a template for
SYBR® green RT-qPCR analysis (ABI 7300 Real-time sys-
tem; Applied Biosystems, Nieuwerkerk a/d lJssel, The Neth-
erlands) using SYBR® Green PCR Master Mix (Applied
Biosystems Nieuwerkerk a/d lJssel, The Netherlands). Se-
quences of the used primers are available upon request. The
amplification efficiencies had values close to 2 for all primer
combinations. The resulting Ct values were converted to ab-
solute amounts of cDNA present in the sample (E-Ct) [28]. To
correct for differences in cDNA load between the different
samples, we normalized the target PCR to a set of reference
PCRs. For this, qPCR data for a selection of candidate refer-
ence genes on experimental and control samples was used as
input for a geNorm analysis [28,40]. Transcript levels of Rho
(rhodopsin), Hprt (hypoxanthine phosphoribosyl transferase),
Nef3 (neurofilament 3), Thy1 (thymus cell antigen 1, θ), and
Prkca (protein kinase Cα) were most stable and used for nor-
malization.
RESULTS
Histology:  To study the effects of IPC, 5 min of ischemia was
induced and followed, after various reperfusion intervals (24
h, 48 h, 7 days), by a full 60 min ischemic insult. Seven days
later, when degeneration has taken its full course, the retinas
were examined using histology. In not-conditioned animals,
retinal ischemia for 60-min leads to a significant reduction in
the number of neurons from the ganglion cell layer (GCL) to
63±11% and to a thinning of the inner plexiform layer (IPL)
to 39±5% (untreated control retinas set at 100%; n=4);
mean±SEM [25]. Animals that were challenged 24 h after in-
duction of tolerance (IPL, 100±8%; GCL, 100±7%; n=3) were
morphologically indistinguishable from a large group of con-
trols (IPL, 100±2%; GCL, 100±5%; n=31), demonstrating
complete protection. This is illustrated in Figure 1. At 48 h, a
minor reduction in IPL (82±18%) and GCL cell count (88±8%)
was found. Seven days after induction of tolerance, the pro-
tective effect was lost for GCL cell count (50±9%) but a mild
protective effect persisted for IPL thickness (60±11%; Figure
1). These results are in agreement with the published findings
on the time course of transient tolerance induction in mouse
and rat retina [10,11]. Based on these results, it was decided
to study the changes in gene expression during the build-up of
tolerance (reperfusion intervals: 1, 3, 6, and, 12 h), at fully
established tolerance (24 and 48 h) and after tolerance had
faded (7 days).
Microarray-based identification of genes of interest:  The
microarray analysis here must be regarded as a screening tool
to select potential genes of interest, to be used as starting point
for Gene Ontology analysis and confirmatory qPCRs on the
individual animals underlying the pooled samples. The fol-
lowing criteria were applied to the microarray data to select
for features-of-interest (see Methods section for details): (1) a
fold change of >1.7, at least at one time point and, (2) a meth-
odological error of p<0.01, assigned by the normalization soft-
ware, to exclude features with a low signal to noise ratio. The
number of selected features for each experimental condition
is presented in Table 1. The list includes a total of 134 differ-
ent features. The 60-mer probe sequences were all blasted
against GenBank, and only those features with a perfect ho-
mology to well annotated genes were used for further study,
resulting in 104 genes-of-interest. Comparison of the differ-
ent time points showed some overlap in the changes in gene
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TABLE 1. NUMBER OF SELECTED FEATURES-OF-INTEREST FOR EACH
EXPERIMENTAL CONDITION
   Title      Signatures   Up   Down
-----------   ----------   --   ----
IPC  1 h         46        34    12
IPC  3 h         34        15    19
IPC  6 h         30        20    10
IPC 12 h         13        12     1
IPC 24 h         21         3    18
IPC 48 h         28         7    21
IPC  7 days      10         7     3
A feature is defined to be of interest when having a dye log ratio
corresponding to a difference of >1.7 fold (up or down) and an as-
signed technical error of p<0.01.
1023expression profile: 18 genes were independently selected at
two different reperfusion times, six at three, and one gene
(Anxa1) at four different time points.
Gene ontology term analysis:  The list of 104 UniGene
cluster IDs of the selected genes-of-interest was subjected to
GO analysis to identify functions/processes of interest [37].
Using GOstat-rat genome database, 68 of the 104 genes (65%)
were associated with one or more GO-terms. Using DAVID-
2006, 90 genes (85%) were associated with one of more GO-
terms by using different annotation sources. The statistically
most significant result from both tools is an overrepresentation
of GO-terms for (1) aminoacyl-tRNA synthetase activity, (2)
translation, (3) amino acid metabolism and transport, (4) cell
death, and (5) transcription, (6) nuclear lamina, and (7) an-
chored to plasma membrane (Table 2). The “Functional anno-
tation clustering” tool of DAVID with high stringency classi-
fication settings confirmed these gene clusters except for
nuclear lamina and anchored to plasma membrane. A sum-
mary is given in Table 3, the complete set is presented in Ap-
pendix 2. The GO-term analysis was also carried out for each
reperfusion interval and identified a significant
overrepresentation of genes associated with transcription at 1
h (p<0.0004), aminoacyl-tRNA synthetases at 24 and 48 h
(p<5.4.10-8 and p<4.2.10-7), and amino acid metabolism at 48
h (p<5.2.10-5) and amino acid transport at 48 h (p<9.3.10-5).
Repeating the GO-term analysis on the list of genes based on
less stringent selection settings (>1.5 fold, p<0.01; 163 genes)
yielded comparable overrepresented GO-terms.
Quantitative polymerase chain reaction:  RT-qPCR as-
says for 21 different members from the 98 genes-of-interest
were carried out on the individual retinal cDNA samples (Table
3 and Appendix 3 for details). The average coefficient of varia-
tion for the 21 genes at the different reperfusion groups was
47±11%, confirming our previous findings on the variation of
expression levels [26,28] and supporting the applied selection
criteria for genes-of-interest selection. Among the transcripts
used for normalization were Nef3 and Thy1, two established
markers for neurodegeneration after full ischemia in the retina
[26,28]. The transcript level stability of these genes demon-
strates the absence of neurodegeneration after IPC.
For each experimental condition, the average change in
transcript level compared to controls was calculated as log10
experimental/control and plotted against the log10 values de-
rived from the microarrays. The result of the linear regression
is presented in Figure 2. The correlation coefficient for all
161 data points: R2=0.54. For data points meeting the
microarray selection criteria (>1.7 fold and p<0.01; n=35)
R2=0.84.
Aminoacyl-tRNA synthetases:  The microarrays revealed
for six different aminoacyl-tRNA synthetases (ARSs) encod-
ing genes (Iars, Lars, Cars, Yars, Gars, Tars) reduced expres-
sion levels by 30-45% at 24 and 48 h after IPC induction. The
transcript levels of Iars, Lars, Yars, and Tars were investi-
gated by qPCR and the average reduction was 31±7% at 24 h
and 49±3% at 48 h. Of the 21 ARSs known to exist, 14 were
represented by probes on the array. Examination of these fea-
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TABLE 2. GENE ONTOLOGY RESULTS FOR THE CHANGES IN GENE EXPRESSION AFTER ISCHEMIC PRECONDITIONING
     GO-terms                                   Genes                               C/T     GO      p
------------------   -----------------------------------------------------------   ------   ---   ------
Aminoacyl-tRNA       Yars, Tars, Gars, Iars                                        4/22     GOs   0.0001
synthetase
activity
Aminoacyl-tRNA       Yars, Tars, Gars, Cars, Lars                                  5        DaV   0.0003
synthetase
activity
Translation          Yars, Tars, Iars, Bzw2, Gtpbp2, Eif2s2                        6/77     GOs   0.0002
Translation          Yars, Tars, Gars, Cars, Lars, Bzw2, Gtpbp2, Eif2s2            8        DaV   0.0001
Amino acid           Yars, Tars, Iars, Asns, Slc6a6, Slc7a1                        6/130    GOs   0.0038
metabolism
Amino acid           Yars, Tars, Gars, Cars, Lars, Asns, Slc6a6, Slc7a1            8        DaV   0.0021
metabolism
Amino acid           Slc3a2, Slc6a6, Slc7a1                                        3/29     GOs   0.0044
transport
Amino acid           Slc3a2, Slc6a6, Slc7a1, Slc38a2                               4        DaV   0.0064
transport
Cell death           Emp1, Anxa1, Trib3, Lcn2, Nr4a1, Klf10, Lgals7, Yars, Ccl6,   10/382   GOs   0.0119
                     Fosl2
Cell death           Emp1, Anxa1, Trib3, Lcn2, Nr4a1, Klf10, Lgals7, Yars, Ccl6,   10       DaV   0.0092
                     Perp
Transcription        Atf3, Trib3, Nr4a1, Nr4a3, Cebpd, Klf10, Egr1, Egr4, Jund,    15/600   GOs   0.0024
                     Fosl2, Fgfbp1, Snf1lk, Zfp36, Fos, Cdc73
Transcription        Atf3, Trib3, Nr4a1, Nr4a3, Cebpd, Klf10, Egr1, Egr4, Jund,    15       DaV   0.0160
                     Fgfbp1, Snf1lk, Zfp36, Arid1a, Klf4, Atf7ip
Nuclear lamina       Emd, Lmna                                                     2/6      GOs   0.0019
Anchored to plasma   Cp,Tmprss8                                                    2/13     GOs   0.0095
membrane
C/T indicates number of signatures genes assigned to GO-term/total number of genes on the array assigned to GO-term (GOstat only), GO
indicates analysis tool, GOs indicates GOstat, DaV indicates David, p indicates Fisher exact p-value.
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TABLE 3. RESULTS OF GENE ONTOLOGY-TERM BASED CLUSTERING
  UniGene
   name       1 h    3 h    6 h    12 h   24 h   48 h   7 d    PCR            Abbreviated description
-----------   ----   ----   ----   ----   ----   ----   ----   ---   --------------------------------------
Aminoacyl-tRNA synthetase, [David Enrichment score 3.59], translation
Tars          -1.1    1.3   -1.3    1.1   -1.7   -1.5    1.0    =    Rat threonyl-tRNA synthetase
Cars          -1.2    1.2   -1.2   -1.1   -1.8   -1.4    1.0         Cysteinyl-tRNA synthetase
Lars (prb1)   -1.2   -1.0   -1.1    1.1   -1.7   -1.7   -1.1    =    Leucyl-tRNA synthetase
Lars (prb2)   -1.3    1.0   -1.1    1.1   -1.7   -1.6   -1.0    =    Leucyl-tRNA synthetase
Yars          -1.0    1.1   -1.1   -1.1   -1.7   -1.5   -1.0    =    Tyrosyl-tRNA synthetase
Gars          -1.2   -1.0   -1.1    1.0   -1.7   -1.4    1.0         Glycyl-tRNA synthetase
Iars (prb1)   -1.1    1.1   -1.2    1.0   -1.8   -1.6   -1.0    =    Isoleucine-tRNA synthetase
Iars (prb2)   -1.3    1.3   -1.2   -1.1   -1.8   -1.5    1.1    =    Isoleucine-tRNA synthetase
Bzw2          -1.1   -1.0   -2.3    1.1   -1.1   -1.3    1.2         Basic leucine zipper and W2 domains 2
Gtpbp2        -1.2    1.0   -1.1   -1.1    1.0   -2.4    1.0         GTP binding protein 2
Eif2s2        -1.3    1.2   -1.2    1.1   -1.4   -1.7    1.0    =    Rat eukaryotic translation initiation
                                                                     factor 2, subunit 2 beta
Mthfd*         1.2    1.0   -2.4   -1.0   -2.3   -2.8   -1.2         Similar to methylenetetrahydrofolate
                                                                     dehydrogenase (NAD)
Pop5*          1.4    1.0   -2.9   -1.1    1.3    1.6    1.8         Processing of precursor 5,
                                                                     ribonuclease P/MRP family
Asns*         -1.0    1.1   -1.1   -1.0   -1.7   -1.5   -1.0    =    Asparagine synthetase
Amino acid transport [David Enrichment score 1.82]
Slc3a2        -1.1    1.2   -1.4   -1.1   -1.8   -1.4   -1.1    =    Activators of dibasic and neutral
                                                                     amino acid transpor, member 2
Slc6a6         1.7   -1.0    1.3   -1.4    1.5    1.3    1.2    =    Neurotransmitter transporter, taurine,
                                                                     member 6
Slc7a1        -1.1    1.4   -1.6   -1.1   -2.7   -2.2   -1.1    =    Cationic amino acid transporter, y+
                                                                     system, member 1
Slc38a2       -1.2    1.0   -1.5    1.0   -1.5   -1.7   -1.1    =    Solute carrier family 38, member 2
Cell death [David Enrichment score 1.88]
Emp1          -1.5   -1.2    3.5    1.9   -1.1   -1.5   -1.3         Epithelial membrane protein 1
Anxa1         -1.7   -2.3    3.8    2.1    1.1   -1.2   -1.1    =    Annexin A1
Trib3         -1.1   -1.2   -2.9   -1.2   -1.3   -1.9   -1.0    =    Tribbles homolog 3 (Drosophila)
Lcn2           1.2    1.2   -1.6    2.3    2.5   -2.0   -1.6         Lipocalin 2
Perp1         -1.3   -1.7    2.3    1.2   -1.2   -1.1   -1.2         PERP, TP53 apoptosis effector
Lgals7        -1.1   -2.7    2.9   -1.2    1.0   -1.0   -1.3         Lectin, galactose binding, soluble 7
Ccl6          -1.5   -1.6    2.2    1.2   -1.0   -1.1   -1.2         Chemokine (C-C motif) ligand 6
Klf10          2.0   -1.1    1.1    1.1    1.0   -1.1   -1.0         Kruppel-like factor 10
Regulation of transcription, DNA-dependent [David Enrichment score 1.55]
Atf3          -1.1   -1.3   -3.1    1.1   -2.0   -3.3   -1.2    =    Activating transcription factor 3
Nr4a1          4.0   -1.4   -1.3   -1.2    1.0   -1.3    1.0    =    Nuclear receptor subfamily 4, group A,
                                                                     member 1
Nr4a3          5.4   -2.4   -2.1    1.0   -1.2   -1.9   -1.8    =    Nuclear receptor subfamily 4, group A,
                                                                     member 3
Cebpd          1.5    1.2    1.2    2.0    1.5   -1.9   -1.0    =    CCAAT/enhancer binding protein
                                                                     (C/EBP), delta
Egr1           5.0    1.2    3.1   -1.1   -1.5   -2.1   -1.1    =    Early growth response 1
Egr4           2.9   -1.4   -1.1   -1.2   -1.1    1.1   -1.2         Early growth response 4
Jund           1.7   -1.0   -1.1   -1.1    1.1   -1.0   -1.0         Jun D proto-oncogene
Fgfbp1        -1.2   -1.3    1.5    1.1   -1.1   -2.0   -1.0         Fibroblast growth factor binding
                                                                     protein 1
Snf1lk         1.2   -2.0   -1.4   -1.1   -1.0   -1.2   -1.2         SNF1-like kinase
Zfp36          1.8    1.1    1.1    1.1   -1.2   -1.2    1.1         Zinc finger protein 36
Arid1a         1.2    1.4    1.2    1.4    1.4    2.7    1.5         AT rich interactive domain 1A (Swi1
                                                                     like)
Klf4           2.1   -1.0   -1.3    1.2   -1.1   -1.3   -1.2         Kruppel-like factor 4 (gut)
Atf7ip        -1.1   -1.1   -2.7    1.1   -1.6   -1.8   -1.9         Activating transcription factor 7
                                                                     interacting protein
c-fos          2.6   -1.4    1.0    1.1   -1.1   -1.3    1.0    =    FBJ murine osteosarcoma viral oncogene
                                                                     homolog (Fos)
1025increased levels thereafter (139% at 6 h, 133% at 12 h, 93% at
24 h). Hmox1 (HO-1, Hsp32) is an extremely sensitive detec-
tor of ischemia [10]. Microarrays showed an increase of 30%
at 1, 3, and 6 h, while qPCR revealed a more robust signifi-
cant increase of 40%, 130%, and 87% at 1, 3, and 6 h.
Both microarray and qPCR did not detect IPC-induced
changes in Hspa1a (Hsp70) or Hspca (Hsp90) transcript lev-
els.
DISCUSSION
 A short period of retinal ischemia establishes a temporal but
robust form of neuroprotection against a subsequent, other-
wise damaging, ischemic insult [10,11,16-19]. This form of
neuroprotection, termed IPC or tolerance, has been observed
in several neuronal and non-neuronal tissues [13,22-24,41].
We  conducted a series of microarray assays to study alter-
ations in the retinal gene expression profile after IPC in order
to gain insight in the response at the transcriptome level that
results in the neuroprotective state. Our knowledge of quanti-
fication of transcript levels in control and ischemic retinas was
©2007 Molecular Vision Molecular Vision 2007; 13:1020-30 <http://www.molvis.org/molvis/v13/a111/>
TABLE 3. CONTINUED.
  UniGene
   name       1 h    3 h    6 h    12 h   24 h   48 h   7 d    PCR            Abbreviated description
-----------   ----   ----   ----   ----   ----   ----   ----   ---   --------------------------------------
Cdc73         -1.2   -2.3   -1.0    1.2    1.2    1.1   -1.1         Cell division cycle 73, Paf1/RNA
                                                                     polymerase II complex component
Fosl2*         1.2   -1.7   -1.2    1.0   -1.1   -1.7   -1.3         Fos-like antigen 2
Hes5*         -1.7    1.0    1.2   -1.1   -1.0    1.0    1.1         Hairy and enhancer of split 5
                                                                     (Drosophila)
Arid2*         1.2   -1.2    1.1    1.0    1.1   -2.3   -1.3         AT rich interactive domain 2 (Arid-rfx
                                                                     like)
Arid5a*        1.8   -1.2   -1.2   -1.0   -1.1   -1.1   -1.1         AT rich interactive domain 5A (Mrf1
                                                                     like)
Nab2*          2.3    1.8    1.3   -1.0    1.2    1.0    1.1    =    Ngfi-A binding protein 2
Lix1*          1.3    2.1    1.0   -1.2    1.0    1.3    1.1         Similar to Lix1 homolog (mouse) like
                                                                     (LOC499677)
Phf20*         1.3    1.7   -1.0   -1.2    1.2    1.0   -1.1         Similar to PHD finger protein 20
Anchored to cell membrane
Cp            -1.2    1.0    1.2    2.0    1.2   -1.2    1.2         Ceruloplasmin
Tmprss8       -2.2   -1.8    1.2    1.2    1.2    1.1    1.3         Transmembrane protease, serine 8
                                                                     (intestinal)
Intermediate filament, cytoskeletal part
Lmna*          1.7    1.3   -1.1   -1.0    1.0   -1.0   -1.0         Lamin A
Gfap*          1.2    1.6    1.4    2.0    1.8   -1.4    1.3         Glial fibrillary acidic protein
Emd*           1.7    1.2    1.1   -1.2   -1.1   -1.0   -1.0         Emerin
Tubb6*         1.6    1.7    1.8    1.2    1.2   -1.5   -1.0         Tubulin, beta 6
Pdlim3*        1.8    1.7    1.2    1.2    1.1    1.0    1.2         PDZ and LIM domain 3
Dsc2*         -1.3    1.4    2.9    1.4   -1.0   -1.2   -1.1         Desmocollin 2
Mpp2*          1.1   -1.1    1.2    2.9    1.1    1.5    1.4         Membrane protein, palmitoylated 2
Enc1*          1.8    1.2    1.9   -1.5    1.7    2.2    3.6         Ectodermal-neural cortex 1
Nexn*         -1.2   -1.0   -1.0    1.0   -1.7   -1.1    1.1         Nexilin
Mfap3*        -1.1    2.4    1.1   -1.1    1.4   -1.0    1.4         Microfibrillar-associated protein 3
Sdc1*         -1.1   -1.8    2.4    1.1   -1.6   -2.0   -2.4         Syndecan 1
Fold change for the different ischemic preconditioning intervals are in red color when fold change is least 1.7-times and the methodological
error is p<0.01, in black when the methodological error is p<0.01. PCR column indicates whether the qPCR assay confirms the array outcome
(=). UniGene names indicated by asterisk are added to the cluster on basis of other functional annotation than GOStat or DAVID. Lars and Iars
were represented by two different probes (prb) on the array.
tures revealed reduced transcript levels also for Sars1, Sars2,
Nars, and Farsla at 24 and 48 h after IPC, although the degree
of change was less prominent with 20-25% reduction. For Vars,
Quars, Wars, Dars, and Kars, no changes greater than 10%
were detected. In summary, nine out of the 14 studied ARSs
showed reduced transcript levels at 24 and 48 h after IPC in-
duction. In addition, several members of the solute carrier fam-
ily, encoding for amino acid transporters (Slc3a2, Slc7a1,
Slc38a2), and the initiation factor Eif2s2 followed the same
pattern of changes with a reduction of 30 and 60% at 24 and
48 h IPC, respectively. Comparable changes were found by
qPCR.
Heat shock proteins:  The transcript level of Hsp1b, also
known as Hsp27, has been reported to be upregulated after
IPC induction, possibly as a consequence of an increased Hif1a
expression [10,14-16]. No significant changes were found for
Hif1a transcript levels either by microarray or by two differ-
ent qPCR assays. Hspb1 was not present on the array design;
it was therefore studied by qPCR only. After IPC induction,
Hsp1b transcript levels peaked at 3 h IPC (457%) with lesser
1026used to formulate selection criteria to identify features-of-in-
terest. Changes in transcript level of at least 1.7 fold were
found for 134 of the 20281 features present on the array at any
time after IPC, with a maximum of 46 features at 1 h after
preconditioning. Not all feature probes could unquestionably
be linked to genes with a proper annotation in rat genomic
databases. This reduced the list to 104 genes-of-interest. The
GO-term analysis on this set of genes identified a significant
overrepresentation of ARS activity, translation, amino acid
metabolism and transport, transcription factors, and cell death.
Aminoacyl-tRNA synthetases:  The reduced transcript lev-
els of nine different ARSs and of genes involved in amino
acid metabolism and transport was restricted to 24 h and 48 h
after IPC, suggesting that these changes may be an effector
mechanism of the neuroprotective state. Some of the
downregulated ARSs form a macromolecular complex with
subunits of elongation factor 1 (Lars, Fars, Gars). Furthermore,
Iars and Lars are integral parts of a multi-ARS complex [42,43].
The precise function of this molecular assembly and the func-
tional roles of components of the multi-ARS complex are not
well understood. However, a reduced expression of ARSs, in
concert with a reduction in expression of amino acid trans-
porters, may lead to diminished efficiency of protein transla-
tion. In addition, expression of Eif2s2 (eukaryotic translation
initiation factor 2, subunit 2/β; Eif2b) was decreased at the
same time. Eif2b is a key limiting factor in the regulation of
protein synthesis and has been linked to cell survival [44,45].
Because the decreased transcript levels are limited to 24-48 h
after IPC induction, a reduction of protein synthesis is corre-
lated with observations that a de novo protein synthesis is re-
quired for the establishment of successful IPC [10,11,18]. In-
hibition of protein synthesis by cycloheximide reduced is-
chemic damage in brain [46] and spinal cord [47,48], show-
ing that suppression of protein synthesis can be beneficial for
cell survival. How an overall down-regulation of the rate of
protein synthesis could mediate effective neuroprotection is
not clear, but it may attenuate the synthesis of proteins that
cause ischemia-mediated cell loss.
Transcription factors:  Changes in the expression of tran-
scription factors in response to IPC is a general finding in
several models [23,24,49]. The GO-term “regulation of tran-
scription” (15 genes) was significantly overrepresented at 1 h
after the induction of IPC. The response of Egr1 (Ngfi-A, Krox-
24, zif268), Nr4a1 (Ngfi-B, Nur77), Egr4 (Ngfi-C) and the
increase of Nab2 (Ngfi-A binding protein 2) may be the result
of an increased nerve growth factor release, as has been ob-
served after rat brain IPC [50,51].
Evidence for a role of Hif1 in brain and retinal precondi-
tioning has been presented [12,14,52]. Our results however
showed no upregulation of Hif1a or of its heterodimerization
partner Hif1b (Arnt) after IPC. qPCR assays with two differ-
ent primer sets confirmed this observation. Moreover, except
for Hsp27, none of the Hif1-dependent genes that are increased
after hypoxic brain conditioning (Epo, Fgf2, and Vegf) were
found to be altered in our study [12,13,52]. Our data are not in
support of Hif1a as an essential mediator of retinal IPC [12,14].
The finding that Hif1a-deficient mice were protected from hy-
poxia-induced cell death suggests that activation of Hif1a could
even be deleterious in vivo [53].
A class of transcription factors commonly implicated in
IPC are Heat Shock Proteins (Hsps) [15,16,23,24,49,54,55].
Retinal IPC increased gene expression of Hspb1 (Hsp27) but
not of Hspa1a (Hsp70) or Hspca (Hsp90) or any other Hsp
encoding genes on the arrays [15]. Our results are therefore in
good agreement with these findings and do not support a domi-
nant role of Hsps in retinal IPC. Hmox1 (Heme oxygenase
(decycling) 1, Hsp32) has a cytoprotective effect in many tis-
sues by attenuating the overall production of reactive oxygen
species [56]. Roth et al. reported the upregulation of Hmox1
protein levels at 24-72 h after retinal IPC [10]. In the model of
cortical spreading depression Hmox1 was increased at 24 h (2
fold) [49]. In line with these findings, both microarrays and
qPCR showed increased Hmox1 transcript levels up to 6 h
after IPC, suggesting a protective role of Hmox1 also in the
retina.
Cell death:  The overrepresentation of genes associated
with cell death indicates that an interference of pathways lead-
ing to cell loss is a target of IPC. Changes in the expression of
Anxa1 (annexin I) and of Trib3 (tribbles homolog 3) have not
yet been associated with IPC. Anxa1 belongs to a family of
Ca2+-dependent phospholipid binding proteins, and although
it was originally described as a phospholipase A2-inhibitory
protein, Anxa1 affects various other components of inflam-
matory responses such as the inhibition of firm adhesion of
leucocytes to endothelium [57,58]. The upregulation of Anxa1
at 6 and 12 h may therefore have an anti-inflammatory effect
and underlie the IPC-dependent prevention of the increase in
the number of rolling leukocytes observed after ischemia
[19,59]. The downregulation of Trib3 may also play a role in
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Figure 2. Linear regression between microarray and qPCR results
both expressed as log10 fold-change for different experimental groups
with reference to the levels in controls.  Each of the 161 data point
shown represents the average of five or six animals; R2=0.54,
y=0.85+0.04 (blue dots and red diamonds). The trend line shown is
based on the subset of microarray data points meeting the selection
criteria (>1.7 fold and p<0.01; n=34) related to 21 different genes-
of-interest; R2=0.85, y=0.99+0.06 (red diamond symbol).
1027cell fate in response to environmental challenges by interact-
ing with apoptosis promoting transcription factors Atf4 and
Chop (Ddit3) [60]. Knockdown of Trib3 expression decreased
endoplasmatic reticulum (ER) stress-dependent cell death [61].
Microarray results of ischemic preconditioning-induced
gene expression changes in other ischemic models:  Given
the fact that IPC is not unique for the retina, it is of potential
interest to compare our findings with the outcome of
microarray studies on preconditioning in other neuronal tis-
sues. However, it must a priori be pointed out that the sensi-
tivity for ischemic damage differs greatly among neuronal tis-
sues. The retina is relatively insensitive to ischemic damage
with cell loss resulting only after 45 min of ischemia, while
IPC can be established by just 5 min of ischemia resulting in
full protection. In other tissues, the duration of the ischemic
episode leading to either IPC or damage is more similar. In
these tissues induction of IPC will also lead to some degree of
cell loss and, consequently, IPC-evoked mechanisms are ob-
scured by damage-related changes. Compared to other neu-
ronal tissues, differentially expressed genes after retinal IPC
are therefore less prone to be a mix of changes leading to pre-
conditioning and neurodegeneration. Four studies were re-
viewed in detail. (1) IPC in the spinal cord is evoked by 3 min
of ischemia while damage and functional loss occurs already
after 10 min [23]. Moreover, spinal cord IPC is not fully pro-
tective against the loss of motor function and number of spi-
nal neurons [54]. Microarray analysis of spinal cord IPC iden-
tified changes in Hspa1a, Mt1a (metallothionein 1a), Egr1
(early growth response 1), and Dusp1 (dual specificity phos-
phatase 1) [23]. Our results show only the transient
upregulation of Egr1 whereas Hspa1a and Ptpn16 (Dusp1)
were not significantly altered, and Mt1a was not represented
by specific probes on our array. (2) The hippocampal CA1
region is prone to ischemic damage by periods as short as 6
min leading to a loss of 73% of pyramidal neurons [24]. Al-
though 2 min of ischemia leads to protection against a full
ischemic insult given three days later, a cell loss of 20% can
not be prevented. The induction of hippocampal IPC was as-
sociated with altered expression of 96 features in the CA1
region [24], including 13 transcription factors of which c-fos,
Egr1, Egr4, Klf10, Nr4a1 are also found in the present study.
(3) Hypoxic preconditioning (1 or 6 h 8% O2) has a
neuroprotective effect on focal cerebral ischemia in mice.
Again, the protection is only partial, reducing the infarct vol-
ume by about 30% [52]. Microarray based screening identi-
fied a differential expression for 21 genes, including 3 genes
identified in the present study (Atf3, Gfap, Cebpd) [13]. (4) In
rat brain, preconditioning by 10 min of transient middle cere-
bral artery occlusion reduced the infarct volume by 38% re-
sulting from 1 h occlusion [55]. In total 32 genes were found
to be differentially expressed after preconditioning. Only
Hspb1 (Hsp27) was also identified by our study.
In conclusion, there is little overlap in the set of genes
found in our study, and the sets found in other precondition-
ing models, which may be attributed to the confounding ef-
fects of neurodegenerative processes taking place in parallel
with the establishment of tolerance. Interestingly, cortical
spreading depression can act as a preconditioning trigger with-
out causing degeneration. A microarray study on rat cortex
isolated after an average of 7 spreading depressions applied
over a period of 2 h identified 353 regulated genes [49]. A
cluster of 36 immediate early genes and transcription factors
were upregulated at 3 h, of which Fosl2, c-fos, Egr1, Egr4,
Atf3, Nr4a1, Nr4a3, and Zfp36 were also identified in our study,
suggesting possible common pathways leading to protection.
Our microarray study on the changes in gene expression
profile after retinal preconditioning has resulted in evidence
that a restriction of protein translation rate may be a potential
effector of neuroprotection. Further research is needed to sub-
stantiate this hypothesis in order to evaluate the protective ef-
fects of protein synthesis inhibition to prevent ganglion cell
loss in experimental models.
ACKNOWLEDGEMENTS
 Supported by grants from: Rotterdamse Vereniging
Blindenbelangen (RVBB), Stichting Blinden-Penning,
Landelijke Stichting voor Blinden en Slechtzienden (LSBS),
Algemene Nederlandse Vereniging ter Voorkoming van
Blindheid (ANVVB), and Stichting OOG.
The authors like to thank K. Bossers, A. Essing, and F. de
Bree for their assistance and helpful suggestions.
REFERENCES
 1. Osborne NN, Melena J, Chidlow G, Wood JP. A hypothesis to
explain ganglion cell death caused by vascular insults at the
optic nerve head: possible implication for the treatment of glau-
coma. Br J Ophthalmol 2001; 85:1252-9.
2. Piltz-seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic
nerve blood flow is diminished in eyes of primary open-angle
glaucoma suspects. Am J Ophthalmol 2001; 132:63-9.
3. Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A. An evalua-
tion of optic disc and nerve fiber layer examinations in moni-
toring progression of early glaucoma damage. Ophthalmology
1992; 99:19-28.
4. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ,
Zack DJ. Retinal ganglion cell death in experimental glaucoma
and after axotomy occurs by apoptosis. Invest Ophthalmol Vis
Sci 1995; 36:774-86.
5. Robin AL, Barnebey HS, Harris A, Osborne NN. Glaucoma man-
agement: beyond intraocular pressure. Ophtalmology Times
1997; 22:S1-23.
6. Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Richter
RC, Witt KA. Clinically detectable nerve fiber atrophy precedes
the onset of glaucomatous field loss. Arch Ophthalmol 1991;
109:77-83.
7. Lam TT, Abler AS, Tso MO. Apoptosis and caspases after ischemia-
reperfusion injury in rat retina. Invest Ophthalmol Vis Sci 1999;
40:967-75.
8. Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an
update of the molecular pathways involved in cell death. Surv
Ophthalmol 1999; 43:S151-61.
9. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Mel-
ena J. Retinal ischemia: mechanisms of damage and potential
therapeutic strategies. Prog Retin Eye Res 2004; 23:91-147.
10. Roth S. Endogenous neuroprotection in the retina. Brain Res Bull
2004; 62:461-6.
11. Roth S, Li B, Rosenbaum PS, Gupta H, Goldstein IM, Maxwell
©2007 Molecular Vision Molecular Vision 2007; 13:1020-30 <http://www.molvis.org/molvis/v13/a111/>
1028KM, Gidday JM. Preconditioning provides complete protection
against retinal ischemic injury in rats. Invest Ophthalmol Vis
Sci 1998; 39:777-85.
12. Grimm C, Hermann DM, Bogdanova A, Hotop S, Kilic U, Wenzel
A, Kilic E, Gassmann M. Neuroprotection by hypoxic precon-
ditioning: HIF-1 and erythropoietin protect from retinal degen-
eration. Semin Cell Dev Biol 2005; 16:531-8.
13. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P,
Bernaudin M. Effect of hypoxic preconditioning on brain ge-
nomic response before and following ischemia in the adult
mouse: identification of potential neuroprotective candidates for
stroke. Neurobiol Dis 2006; 21:18-28.
14. Whitlock NA, Agarwal N, Ma JX, Crosson CE. Hsp27
upregulation by HIF-1 signaling offers protection against reti-
nal ischemia in rats. Invest Ophthalmol Vis Sci 2005; 46:1092-
8.
15. Li Y, Roth S, Laser M, Ma JX, Crosson CE. Retinal precondi-
tioning and the induction of heat-shock protein 27. Invest
Ophthalmol Vis Sci 2003; 44:1299-304.
16. Whitlock NA, Lindsey K, Agarwal N, Crosson CE, Ma JX. Heat
shock protein 27 delays Ca2+-induced cell death in a caspase-
dependent and -independent manner in rat retinal ganglion cells.
Invest Ophthalmol Vis Sci 2005; 46:1085-91.
17. Li B, Roth S. Retinal ischemic preconditioning in the rat: re-
quirement for adenosine and repetitive induction. Invest
Ophthalmol Vis Sci 1999; 40:1200-16.
18. Li B, Yang C, Rosenbaum DM, Roth S. Signal transduction
mechanisms involved in ischemic preconditioning in the rat
retina in vivo. Exp Eye Res 2000; 70:755-65.
19. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Nishijima K,
Miyamoto K, Nishiwaki H, Honda Y, Ogura Y. Inhibitory effect
of ischemic preconditioning on leukocyte participation in reti-
nal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2001;
42:2380-5.
20. Sakamoto K, Yonoki Y, Kubota Y, Kuwagata M, Saito M,
Nakahara T, Ishii K. Inducible nitric oxide synthase inhibitors
abolished histological protection by late ischemic precondition-
ing in rat retina. Exp Eye Res 2006; 82:512-8.
21. Roth S, Dreixler JC, Shaikh AR, Lee KH, Bindokas V. Mito-
chondrial potassium ATP channels and retinal ischemic precon-
ditioning. Invest Ophthalmol Vis Sci 2006; 47:2114-24.
22. Gidday JM. Cerebral preconditioning and ischaemic tolerance.
Nat Rev Neurosci 2006; 7:437-48.
23. Carmel JB, Kakinohana O, Mestril R, Young W, Marsala M, Hart
RP. Mediators of ischemic preconditioning identified by
microarray analysis of rat spinal cord. Exp Neurol 2004; 185:81-
96.
24. Kawahara N, Wang Y, Mukasa A, Furuya K, Shimizu T,
Hamakubo T, Aburatani H, Kodama T, Kirino T. Genome-wide
gene expression analysis for induced ischemic tolerance and
delayed neuronal death following transient global ischemia in
rats. J Cereb Blood Flow Metab 2004; 24:212-23.
25. Dijk F, Kamphuis W. Ischemia-induced alterations of AMPA-
type glutamate receptor subunit. Expression patterns in the rat
retina—an immunocytochemical study. Brain Res 2004;
997:207-21.
26. Dijk F, van Leeuwen S, Kamphuis W. Differential effects of is-
chemia/reperfusion on amacrine cell subtype-specific transcript
levels in the rat retina. Brain Res 2004; 1026:194-204.
27. Osborne NN. Neuroprotection to the retina: relevance in glau-
coma. In: Drance SM, editor. Vascular risk factors and
neuroprotection in glaucoma: update 1996. New York: Kugler
Publications; 1997. p. 139-155.
28. Dijk F, Kraal-Muller E, Kamphuis W. Ischemia-induced changes
of AMPA-type glutamate receptor subunit expression pattern in
the rat retina: a real-time quantitative PCR study. Invest
Ophthalmol Vis Sci 2004; 45:330-41.
29. MAQC Consortium, Shi L, Reid LH, Jones WD, Shippy R,
Warrington JA, Baker SC, Collins PJ, de Longueville F,
Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist
RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW,
Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer
EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M,
Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas
AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A,
Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM,
Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison
TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang
H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L,
Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris
SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jack-
son SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ,
Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B,
McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N,
Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Pe-
ters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F,
Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M,
Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H,
Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova
I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y,
Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W,
Zhang L, Zhong S, Zong Y, Slikker W Jr. The MicroArray Qual-
ity Control (MAQC) project shows inter- and intraplatform re-
producibility of gene expression measurements. Nat Biotechnol
2006; 24:1151-61.
30. Hughes TR, Mao M, Jones AR, Burchard J, Marton MJ, Shannon
KW, Lefkowitz SM, Ziman M, Schelter JM, Meyer MR,
Kobayashi S, Davis C, Dai H, He YD, Stephaniants SB, Cavet
G, Walker WL, West A, Coffey E, Shoemaker DD, Stoughton
R, Blanchard AP, Friend SH, Linsley PS. Expression profiling
using microarrays fabricated by an ink-jet oligonucleotide syn-
thesizer. Nat Biotechnol 2001; 19:342-7.
31. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R,
Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ,
King AM, Meyer MR, Slade D, Lum PY, Stepaniants SB, Shoe-
maker DD, Gachotte D, Chakraburtty K, Simon J, Bard M,
Friend SH. Functional discovery via a compendium of expres-
sion profiles. Cell 2000; 102:109-26.
32. Roberts CJ, Nelson B, Marton MJ, Stoughton R, Meyer MR,
Bennett HA, He YD, Dai H, Walker WL, Hughes TR, Tyers M,
Boone C, Friend SH. Signaling and circuitry of multiple MAPK
pathways revealed by a matrix of global gene expression pro-
files. Science 2000; 287:873-80.
33. Brandish PE, Su M, Holder DJ, Hodor P, Szumiloski J, Kleinhanz
RR, Forbes JE, McWhorter ME, Duenwald SJ, Parrish ML, Na
S, Liu Y, Phillips RL, Renger JJ, Sankaranarayanan S, Simon
AJ, Scolnick EM. Regulation of gene expression by lithium and
depletion of inositol in slices of adult rat cortex. Neuron 2005;
45:861-72.
34. Carter MG, Hamatani T, Sharov AA, Carmack CE, Qian Y, Aiba
K, Ko NT, Dudekula DB, Brzoska PM, Hwang SS, Ko MS. In
situ-synthesized novel microarray optimized for mouse stem cell
and early developmental expression profiling. Genome Res
2003; 13:1011-21.
35. Kamphuis, W, Dijk, F, Kraan, W, Van Soest, S, Bergen, AAB
Transfer of lens specific transcripts to retinal RNA samples may
©2007 Molecular Vision Molecular Vision 2007; 13:1020-30 <http://www.molvis.org/molvis/v13/a111/>
1029underlie observed changes in crystallin-gene transcript levels
after ischemia. Mol Vis 2007; 13:220-8.
36. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC,
Lempicki RA. DAVID: Database for Annotation, Visualization,
and Integrated Discovery. Genome Biol 2003; 4:P3.
37. Beissbarth T, Speed TP. GOstat: find statistically overrepresented
Gene Ontologies within a group of genes. Bioinformatics 2004;
20:1464-5.
38. Bluthgen N, Brand K, Cajavec B, Swat M, Herzel H, Beule D.
Biological profiling of gene groups utilizing Gene Ontology.
Genome Inform 2005; 16:106-15.
39. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA.
Identifying biological themes within lists of genes with EASE.
Genome Biol 2003; 4:R70.
40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F. Accurate normalization of real-time quan-
titative RT-PCR data by geometric averaging of multiple inter-
nal control genes. Genome Biol 2002; 3:RESEARCH0034.
41. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington
CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE,
Chu X, Simon RP. Effect of ischaemic preconditioning on ge-
nomic response to cerebral ischaemia: similarity to
neuroprotective strategies in hibernation and hypoxia-tolerant
states. Lancet 2003; 362:1028-37.
42. Han JM, Kim JY, Kim S. Molecular network and functional im-
plications of macromolecular tRNA synthetase complex.
Biochem Biophys Res Commun 2003; 303:985-93.
43. Sang Lee J, Gyu Park S, Park H, Seol W, Lee S, Kim S. Interac-
tion network of human aminoacyl-tRNA synthetases and sub-
units of elongation factor 1 complex. Biochem Biophys Res
Commun 2002; 291:158-64.
44. Pavitt GD. eIF2B, a mediator of general and gene-specific trans-
lational control. Biochem Soc Trans 2005; 33:1487-92.
45. Proud CG. eIF2 and the control of cell physiology. Semin Cell
Dev Biol 2005; 16:3-12.
46. Snider BJ, Du C, Wei L, Choi DW. Cycloheximide reduces inf-
arct volume when administered up to 6 h after mild focal is-
chemia in rats. Brain Res 2001; 917:147-57.
47. Kato H, Kanellopoulos GK, Matsuo S, Wu YJ, Jacquin MF, Hsu
CY, Choi DW, Kouchoukos NT. Protection of rat spinal cord
from ischemia with dextrorphan and cycloheximide: effects on
necrosis and apoptosis. J Thorac Cardiovasc Surg 1997; 114:609-
18.
48. Liang CL, Yang LC, Lu K, Hsu HC, Cho CL, Chen SD, Huang
HY, Chen HJ. Neuroprotective synergy of N-methyl-D-aspar-
tate receptor antagonist (MK801) and protein synthesis inhibi-
tor (cycloheximide) on spinal cord ischemia-reperfusion injury
in rats. J Neurotrauma 2003; 20:195-206.
49. Urbach A, Bruehl C, Witte OW. Microarray-based long-term de-
tection of genes differentially expressed after cortical spread-
ing depression. Eur J Neurosci 2006; 24:841-56.
50. Naylor M, Bowen KK, Sailor KA, Dempsey RJ, Vemuganti R.
Preconditioning-induced ischemic tolerance stimulates growth
factor expression and neurogenesis in adult rat hippocampus.
Neurochem Int 2005; 47:565-72.
51. Truettner J, Busto R, Zhao W, Ginsberg MD, Perez-Pinzon MA.
Effect of ischemic preconditioning on the expression of puta-
tive neuroprotective genes in the rat brain. Brain Res Mol Brain
Res 2002; 103:106-15.
52. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E,
Schumann-Bard P. Normobaric hypoxia induces tolerance to
focal permanent cerebral ischemia in association with an in-
creased expression of hypoxia-inducible factor-1 and its target
genes, erythropoietin and VEGF, in the adult mouse brain. J
Cereb Blood Flow Metab 2002; 22:393-403.
53. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw
B, Ouyang L, Dragatsis I, Zeitlin S, Johnson RS, Lipton SA,
Barlow C. Brain-specific knock-out of hypoxia-inducible fac-
tor-1alpha reduces rather than increases hypoxic-ischemic dam-
age. J Neurosci 2005; 25:4099-107. Erratum in: J Neurosci 2005;
25:1 p following 4888.
54. Cizkova D, Carmel JB, Yamamoto K, Kakinohana O, Sun D,
Hart RP, Marsala M. Characterization of spinal HSP72 induc-
tion and development of ischemic tolerance after spinal ischemia
in rats. Exp Neurol 2004; 185:97-108.
55. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. Putative en-
dogenous mediators of preconditioning-induced ischemic tol-
erance in rat brain identified by genomic and proteomic analy-
sis. J Neurochem 2004; 89:73-89.
56. Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW. Heme oxy-
genase system in ischemia and reperfusion injury. Ann Trans-
plant 2004; 9:84-7.
57. Hayhoe RP, Kamal AM, Solito E, Flower RJ, Cooper D, Perretti
M. Annexin 1 and its bioactive peptide inhibit neutrophil-en-
dothelium interactions under flow: indication of distinct recep-
tor involvement. Blood 2006; 107:2123-30.
58. Parente L, Solito E. Annexin 1: more than an anti-phospholipase
protein. Inflamm Res 2004; 53:125-32.
59. Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Honda
Y. In vivo evaluation of leukocyte dynamics in retinal ischemia
reperfusion injury. Invest Ophthalmol Vis Sci 1998; 39:793-800.
60. Hegedus Z, Czibula A, Kiss-Toth E. Tribbles: novel regulators of
cell function; evolutionary aspects. Cell Mol Life Sci 2006;
63:1632-41.
61. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3, a
novel ER stress-inducible gene, is induced via ATF4-CHOP
pathway and is involved in cell death. EMBO J 2005; 24:1243-
55.
©2007 Molecular Vision Molecular Vision 2007; 13:1020-30 <http://www.molvis.org/molvis/v13/a111/>
1030
The appendices are available in the online version of this article at http://www.molvis.org/molvis/v13/a111/.
The print version of this article was created on 28 Jun 2007. This reflects all typographical corrections and errata to the article through that
date. Details of any changes may be found in the online version of the article.  α